Clinical Trials Logo

Clinical Trial Summary

Pyogenic liver abscess is one of the most common visceral abscesses, its incidence is increasing worldwide. According to the previous literature, the mortality rate of pyogenic liver abscess is as high as 31% and become a serious social health problem. However, the data of prospective observational real-world studies are scarce and no relevant research of the liver histological change has been reported, so the long-term prognosis and the risk factors for pyogenic liver abscess are still unknown. Patients will be followed up prospectively for a period of 2 years and observed clinical prognosis (all-cause mortality, the recurrence rate, and the rehospitalization rate). The investigators will investigate the predictive value of clinical risk factors for clinical prognosis and establish clinical prediction models to predict the long-term prognosis of pyogenic liver abscesses.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT05213949
Study type Observational
Source Nanfang Hospital of Southern Medical University
Contact Xuyen Xu, MD
Phone 020-62786539
Email [email protected]
Status Recruiting
Phase
Start date January 1, 2022
Completion date January 1, 2025

See also
  Status Clinical Trial Phase
Not yet recruiting NCT05450185 - Filter Lifespan in Continuous Renal Replacement Therapy
Not yet recruiting NCT05459155 - Effect of Synapse Medicine Decision Support on Inpatient Pharmacist Efficacy and Efficiency N/A
Not yet recruiting NCT02222779 - Quantification of Transition Metals N/A
Completed NCT01976234 - Stored RBC Transfusion and Immonomodulation N/A
Completed NCT01530763 - Safety and Efficacy Study of Ceftaroline Versus a Comparator in Pediatric Subjects With Community Acquired Bacterial Pneumonia (CABP) Phase 2/Phase 3
Completed NCT02345135 - Susceptibility to Infections in Ataxia Telangiectasia N/A
Completed NCT01158560 - A Trial of Vitamin D and Health Advice for the Prevention of Upper Respiratory Tract Infections Phase 3
Completed NCT01176786 - Reusable Versus Disposable Draping System in Breast Reconstruction Surgery N/A
Not yet recruiting NCT05449756 - A Follow-up Study With Children Who Participated in the TEMPO Study in Their First Year of Life
Completed NCT02802059 - E. Coli Nissle 1917 - Suspension for Infection Prophylaxis Phase 3
Recruiting NCT05289674 - The Effect of Lactoferrin in High Calorie Formula on IL-6 and IL10 in Children With Failure to Thrive and Infection N/A
Enrolling by invitation NCT05080920 - Rosmalip® for Cancer Infections Prevention N/A
Recruiting NCT05287438 - Next Generation Sequencing Versus Traditional Cultures for Clinically Infected Penile Implants: Impact of Culture Identification on Outcomes N/A
Recruiting NCT05069623 - A Phase 1/2 Study to Determine Safety and Immunogenicity of Two COVID 19 Vaccines VB10.2129 (RBD Candidate) and VB10.2210 (T Cell Candidate) Previously Vaccinated in Healthy Adult Volunteers Phase 1/Phase 2
Completed NCT01949103 - TD-1607 MAD Study in Healthy Subjects Phase 1
Completed NCT01645735 - Evaluation of Ceftaroline Fosamil Versus a Comparator in Adult Subjects With Community-acquired Bacterial Pneumonia (CABP) With Risk for Methicillin-resistant Staphylococcus Aureus Phase 4
Completed NCT01669980 - Safety and Efficacy Study of Ceftaroline Versus a Comparator in Pediatric Subjects With Complicated Community Acquired Pneumonia (CABP) Phase 4
Completed NCT01021995 - Echinacea Safety Study Phase 4
Completed NCT00148278 - Norepinephrine Plus Dobutamine Versus Epinephrine Alone for the Management of Septic Shock Phase 2/Phase 3
Recruiting NCT05149547 - mNGS Versus Blood Culture in FN